It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The placenta is crucial for fetal development, yet the impact of environmental stressors such as arsenic exposure remains poorly understood. We apply single-cell RNA sequencing to analyze the response of the mouse placenta to arsenic, revealing cell-type-specific gene expression, function, and pathological changes. Notably, the Prap1 gene, which encodes proline-rich acidic protein 1 (PRAP1), is significantly upregulated in 26 placental cell types including various trophoblast cells. Our study shows a female-biased increase in PRAP1 in response to arsenic and localizes it in the placenta. In vitro and ex vivo experiments confirm PRAP1 upregulation following arsenic treatment and demonstrate that recombinant PRAP1 protein reduces arsenic-induced cytotoxicity and downregulates cell cycle pathways in human trophoblast cells. Moreover, PRAP1 knockdown differentially affects cell cycle processes, proliferation, and cell death depending on the presence of arsenic. Our findings provide insights into the placental response to environmental stress, offering potential preventative and therapeutic approaches for environment-related adverse outcomes in mothers and children.
Environmental stressors have been associated with placental dysfunction and pregnancy complications. Here, the authors reveal gene expression changes in the mouse placenta exposed to arsenic at single-cell resolution and identify a potential therapeutic target to mitigate its harmful effects on pregnancy and fetal development.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details







1 Harvard T.H. Chan School of Public Health, Department of Biostatistics, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X)
2 University of Rochester, Department of Environmental Medicine, School of Medicine and Dentistry, Rochester, USA (GRID:grid.16416.34) (ISNI:0000 0004 1936 9174)
3 University of Rochester, Division of Allergy, Immunology and Rheumatology, Department of Medicine, Rochester, USA (GRID:grid.16416.34) (ISNI:0000 0004 1936 9174)
4 University of Rochester, Department of Obstetrics and Gynecology, School of Medicine and Dentistry, Rochester, USA (GRID:grid.16416.34) (ISNI:0000 0004 1936 9174)
5 University of Rochester, Department of Pediatrics, School of Medicine and Dentistry, Rochester, USA (GRID:grid.16416.34) (ISNI:0000 0004 1936 9174)
6 Harvard T.H. Chan School of Public Health, Department of Biostatistics, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X); Harvard University, Department of Statistics, Cambridge, USA (GRID:grid.38142.3c) (ISNI:0000 0004 1936 754X)